Wenliang Liu, Siying Ren, Ying Xiao, Lulu Yang, Chao Zeng, & Yan Hu. (2022). Neoadjuvant targeted therapy for resectable EGFR-mutant non-small cell lung cancer: Current status and future considerations. Frontiers Media S.A..
Chicago Style (17th ed.) CitationWenliang Liu, Siying Ren, Ying Xiao, Lulu Yang, Chao Zeng, and Yan Hu. Neoadjuvant Targeted Therapy for Resectable EGFR-mutant Non-small Cell Lung Cancer: Current Status and Future Considerations. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationWenliang Liu, et al. Neoadjuvant Targeted Therapy for Resectable EGFR-mutant Non-small Cell Lung Cancer: Current Status and Future Considerations. Frontiers Media S.A., 2022.
Warning: These citations may not always be 100% accurate.